Dramatic decrease of PEPCK, FBP1 and G6Pase gene expression was observed in hepatocellular carcinoma (HCC) developed in a mouse model and in the majority of primary human HCCs [5]. The gene discussed is PCK2; the disease is hepatocellular carcinoma.